Aripiprazole Injection
Last Updated: October 19, 2013
Status: Current
Products Affected - Description
Abilify 9.75 mg intramuscular injection, BMS
Reason for the Shortage
- BMS could not provide a reason for the shortage.
- BMS is the sole manufacturer of aripiprazole intramuscular injection.
- This shortage does not affect Abilify oral dosage forms.
Estimated Resupply Dates
BMS has available Abilify 9.75 mg intramuscular injection (NDC 59148-0016-65).
Related Shortages
- Olanzapine Injection — Resolved
Updated
October 19, 2011; October 5, 2011; September 13, 2011; September 7, 2011; August 22, 2011; July 26, 2011; July 18, 2011; June 23, 2011; May 16, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.
